These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 3857611

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Warfarin inhibition of vitamin K 2,3-epoxide reductase in rat liver microsomes.
    Fasco MJ, Principe LM, Walsh WA, Friedman PA.
    Biochemistry; 1983 Nov 22; 22(24):5655-60. PubMed ID: 6652076
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Purified vitamin K epoxide reductase alone is sufficient for conversion of vitamin K epoxide to vitamin K and vitamin K to vitamin KH2.
    Chu PH, Huang TY, Williams J, Stafford DW.
    Proc Natl Acad Sci U S A; 2006 Dec 19; 103(51):19308-13. PubMed ID: 17164330
    [Abstract] [Full Text] [Related]

  • 7. Co-purification of microsomal epoxide hydrolase with the warfarin-sensitive vitamin K1 oxide reductase of the vitamin K cycle.
    Guenthner TM, Cai D, Wallin R.
    Biochem Pharmacol; 1998 Jan 15; 55(2):169-75. PubMed ID: 9448739
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Species comparison of vitamin K1 2,3-epoxide reductase activity in vitro: kinetics and warfarin inhibition.
    Wilson CR, Sauer JM, Carlson GP, Wallin R, Ward MP, Hooser SB.
    Toxicology; 2003 Aug 01; 189(3):191-8. PubMed ID: 12832152
    [Abstract] [Full Text] [Related]

  • 10. Effect of N-methyl-thiotetrazole on vitamin K epoxide reductase.
    Creedon KA, Suttie JW.
    Thromb Res; 1986 Oct 15; 44(2):147-53. PubMed ID: 3787564
    [Abstract] [Full Text] [Related]

  • 11. Tissue distribution and warfarin sensitivity of vitamin K epoxide reductase.
    Hazelett SE, Preusch PC.
    Biochem Pharmacol; 1988 Mar 01; 37(5):929-34. PubMed ID: 3345202
    [Abstract] [Full Text] [Related]

  • 12. Normal and warfarin-resistant rat hepatocyte metabolism of vitamin K 2,3-epoxide: evidence for multiple pathways of hydroxyvitamin K formation.
    Trivedi LS, Rhee M, Galivan JH, Fasco MJ.
    Arch Biochem Biophys; 1988 Jul 01; 264(1):67-73. PubMed ID: 3395132
    [Abstract] [Full Text] [Related]

  • 13. Solubilization and characterization of vitamin K epoxide reductase from normal and warfarin-resistant rat liver microsomes.
    Hildebrandt EF, Preusch PC, Patterson JL, Suttie JW.
    Arch Biochem Biophys; 1984 Feb 01; 228(2):480-92. PubMed ID: 6696443
    [Abstract] [Full Text] [Related]

  • 14. Identification of a warfarin-sensitive protein component in a 200S rat liver microsomal fraction catalyzing vitamin K and vitamin K 2,3-epoxide reduction.
    Lee JJ, Principe LM, Fasco MJ.
    Biochemistry; 1985 Dec 03; 24(25):7063-70. PubMed ID: 4084561
    [Abstract] [Full Text] [Related]

  • 15. 2-(Fluoromethyl)-3-phytyl-1,4-naphthoquinone and its 2,3-epoxide. Inhibition of vitamin K epoxide reductase.
    Silverman RB, Oliver JS.
    J Med Chem; 1989 Sep 03; 32(9):2138-41. PubMed ID: 2769684
    [Abstract] [Full Text] [Related]

  • 16. Substituted vitamin K epoxide analogues. New competitive inhibitors and substrates of vitamin K1 epoxide reductase.
    Ryall RP, Nandi DL, Silverman RB.
    J Med Chem; 1990 Jun 03; 33(6):1790-7. PubMed ID: 2342073
    [Abstract] [Full Text] [Related]

  • 17. Vitamin K epoxide reductase activity and its inhibition by warfarin in young and old rats.
    Hallak HO, Wedlund PJ.
    Drug Metab Dispos; 1991 Jun 03; 19(1):278-9. PubMed ID: 1673414
    [No Abstract] [Full Text] [Related]

  • 18. Lapachol inhibition of vitamin K epoxide reductase and vitamin K quinone reductase.
    Preusch PC, Suttie JW.
    Arch Biochem Biophys; 1984 Nov 01; 234(2):405-12. PubMed ID: 6497379
    [Abstract] [Full Text] [Related]

  • 19. Evidence that warfarin anticoagulant action involves two distinct reductase activities.
    Fasco MJ, Hildebrandt EF, Suttie JW.
    J Biol Chem; 1982 Oct 10; 257(19):11210-2. PubMed ID: 6811577
    [Abstract] [Full Text] [Related]

  • 20. B16 tumor cells contain a warfarin sensitive vitamin K1 2,3 epoxide reductase.
    Uitendaal MP, Thijssen HH, Drittij-Reijnders MJ, Hoeijmakers MJ.
    Biochem Biophys Res Commun; 1986 Jun 30; 137(3):1015-20. PubMed ID: 3729947
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.